The report covers the detailed analysis of the trends, future estimations, and a thorough study of the global face mask market on the basis of type, material, nature, and distribution channel. It analyzes government regulations, policies, and patents to provide information on the current market trends and suggests future growth opportunities globally.

Erythropoietin is a hormone produced primarily by capillary network of the kidney's renal cortex, with small amounts produced by liver and brain. It stimulates production of red blood cells (RBCs). Erythropoietin (EPO) is a protein generated by red blood cells. It is also known as hematopoietin or hemopoietin. Kidney cells produce and release erythropoietin when blood oxygen levels are extremely low. Erythropoietin drugs are used to treat anemia caused by chronic kidney disease (CKD), cancer, and human immunodeficiency virus (HIV). The report provides market dynamics and trends related to the global erythropoietin drugs market. The study estimates revenue generated from sales of erythropoietin products; however, it excludes total revenue for bio similar products. The valuations comprise revenue generated from erythropoietin products such as epoetinalfa, epoetin-beta, and darbepoetin-alfa.

Bioadhesives are defined as naturally occurring polymeric materials, which possess adhesive characteristics and can adhere to biological surfaces. This substance includes glues created by using biological intermediates such as starch, cellulose, or gelatin. With the growing popularity of bioadhesives, owing to their environmentfriendly nature, they are preferred over synthetic adhesives. These adhesives find their application in several end-use industries such as wood, packaging & paper, construction, and medical industries.

The report includes the revenue generated from the sales of vaccines used for the prevention of various animal diseases. Recent advancements and developments in the animal vaccines market have enhanced the efficiency of these drugs. Drivers, restraints, and opportunities are explained in detail to understand the market dynamics. Key strategies adopted by the potential market leaders to facilitate effective planning and decision-making are also discussed.

Animal model is a non-human species utilized in medical research as it shows related aspects of diseases and disorders that are found in humans. It is used to test the efficacy of the treatment cycle and effectiveness of a drug for specific disease condition. The report provides market dynamics and trends related to the animal model market. The study estimates the revenue generated from the sales of animal model types. The valuations comprise revenue generated from animal model types such as rat, mice, guinea pigs, rabbits, and others.

An ultrasonic sensor works by releasing sound waves at high frequency for humans to hear, and when sound is reflected, it calculates the distance based on the time it took to travel. It is widely used in many applications such as presence detection, stacking height control, robotic sensing, liquid level control, loop control, full detection, through-beam detection for high-speed counting, irregular parts detection for hoppers and feeder bowls, 45° deflection, thread or wire break detection, and contouring using ultrasonic systems.

The global urology care devices and platforms market has the presence of various key medical device companies operating in the market. The major medical device companies operating in the market include Baxter International Inc., Olympus Corporation, Boston Scientific Corporation, Becton, Dickinson and Company, and Medtronic plc. The companies offer a diverse product portfolio, including dialysis devices, lasers and lithotripsy devices, and consumables such as guidewires and catheters, stents, and biopsy devices.

产业痛点：目前我国医药产业总体在政策导向下面临转型压力，而我国传统医药产 业痛点主要集中于经营模式过于单一，线上监管滞后以及针对供应链管理的不足。 亟需医药产业互联网协同创新，优化信息流。 

2020 年，新冠疫情席卷全球，对各经济体的生产制造、消费投资、社会治理、民众信心等造成全方位冲击，全球经济陷入“大萧条”以来最严重衰退，预计 2020 年全球经济萎缩 3.5%。我国统筹疫情防控和经济社会发展取得重大成果，经济运行持续稳定恢复，就业民生保障有力，经济社会发展主要目标任务完成情况好于预期，初步核算，2020 年国内生产总值比上年增长2.3%。政策方面，多部委出台疫情防控及配套政策，国家药品集采有序推进，国家医保制度不断完善，医疗监管政策全面趋严，多政策促“互联网+医疗健康”向纵深发展，医保支付结算服务持续优化。